(NASDAQ: TOI) Oncology Institute's forecast annual revenue growth rate of 16.43% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.59%.
Oncology Institute's revenue in 2025 is $461,039,000.On average, 5 Wall Street analysts forecast TOI's revenue for 2025 to be $49,739,637,877, with the lowest TOI revenue forecast at $48,014,029,174, and the highest TOI revenue forecast at $51,980,764,802. On average, 5 Wall Street analysts forecast TOI's revenue for 2026 to be $61,447,017,337, with the lowest TOI revenue forecast at $58,233,882,773, and the highest TOI revenue forecast at $68,198,928,701.
In 2027, TOI is forecast to generate $73,301,968,807 in revenue, with the lowest revenue forecast at $71,124,789,753 and the highest revenue forecast at $76,205,202,151.